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more severely diseased population with more prior myocardial infarctions
(Mil, lower ejection fractions (H) and more 3 vessel or left main disease
(3 VD/LM). the angiographic success (Ang Succ) and residual stenosis (%DS
Post) have improved, without increased complications of a wave myocardial
infarction (0 MIl. emergency coronary bypass surgery (CABG) or in hospital
death (Death), In recent years new interventional devices (New Dev) have
been used in a large minority of patients, contributing to the improved re-
sults.
All comparisons between the 2 groups were not statistically significant.
In Conclusion: After S placement. irrespective of SVG age, 1) acute and late
angiographic results and restenosis rates were similar and 2) clinical results
(i.e. procedural success, major complications, target lesion revascularization
and 12-months event free survival) were comparable. Thus, unlike PTCA, in
appropriate SVG lesions, the favorable early and 12-month clinical outcomes
after S therapy are not diminished by advanced SVG age.
2:30
2:15
1710-21 Coronary Stents Versus Balloon Angioplasty for
Aorto-Coronary Saphenous Vein Bypass Graft
Disease: Interim Results of a Randomized Trial
Fibrotic Ectatic p
Reference EEM area (mm2) 19.8 ± 7.3 18.6 ± 5.9 NS
Reference lumen area (mm2) 106 ± 4.4 106 ± 3.6 NS
Reference plaque area (mm2) 106 ± 100 8.0 ± 3.8 0.0052
Lesion site pre-intervention
Angiographic % diameter stenosis 63 ± 20 60 ± 22 NS
EEM area (mm 2) 16.1 ± 6.8 258 ± 10.6 <00001
Lumen area (mm2) 2.6 ± 2.2 3.6 ± 2.7 00016
Plaque + media area (mm2) 13.5 ± 6.4 21.9 ± 8.4 <00001
Arc of calcium n 61 ± 83 26 ± 54 0.001
Lesion/Reference plaque area 1.6 ± 0.7 3.1 ± 1.3 <0.0001
Lesion site post-intervention
Angiographic %diameter stenosis 17 ± 17 12 ± 19 0.0903
Lumen area (mm2) 67 ± 25 85 ± 2.9 0.0001
Follow-up angiographic %diameter stenosis 54 ± 33 35 ± 32 0.0329
16% of "fibrotic" had a lesion plaque area < reference. Importantly, (1)
post-intervention minimum lumen areas were significantly smaller in fibrotic
lesions, and (2) at follow-up the angiographic % diameter stenosis was signif-
icantly larger in fibrotic lesions. We Conclude: 40% of vein graft lesions may
be classified as "fibrotic". "Fibrotic" lesions have a decreased plaque bur-
den and more lesion-associated calcium. Lumen compromise results from
vessel retraction (?periadventitial fibrosis). In these lesions it may be more
difficult to achieve optimal final lumen dimensions resulting in more frequent
restenosis.
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1710-41 The Dimorphic Pathology of Vein Graft Lesions
Effects Acute Procedural and Late Angiographic
Outcomes
Gary S. Mintz, Jeffrey J. Popma, Augusto D. Pichard, Kenneth M. Kent, Lowell
F. Satler, S. Chiu Wong, Mun K. Hong, Jack A. Painter, Julie Mackenzie, Martin
B. Leon. Washington Hospital Center. Washington, DC
In an attempt to understand better the pathology and results of transcatheter
therapy of vein graft lesions, we performed intravascular ultrasound and
quantitative angiographic analysis of 244 nonostial vein graft lesions. Pre-
and post-intervention lesion site external elastic membrane (EEM), lumen,
and plaque cross-sectional areas, calcium, and % cross-sectional narrowing
(plaque/EEM area) were compared to a proximal reference site (most normal
looking cross-section within 10 mm proximal to the lesion). Lesions were di-
vided into two groups: 98 lesions with lesion EEM ::; reference ("fibrotic");
146 lesions with lesion EEM > reference ("ectatic"). There was no difference
in vein graft age, lesion length, or history of restenosis between the two
groups.
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1710-5\ Progressive Deterioration in Late (2-Year) Clinical
Outcomes After Stent Implantation in Saphenous
Vein Grafts: The Multicenter JJIS Experience
Michael H. Sketch, Jr., S. Chiu Wong, Ya Chien Chuang, Harry R. Phillips,
Richard Heuser, Michael Savage, Richard S. Stack, Donald S. Bairn, Richard
A. Schatz, Martin B. Leon, JJIS Stent Investigators. Duke University Medical Center.
Durham, N. C.
Late clinical follow-up (after I-year) in patients treated with native coronary
stents demonstrates no further clinical events (death or MI) and rare delayed
target lesion revascularization (TLR = repeat PTCA or CABG). To examine
the long-term effects of stent placement in saphenous vein grafts (SVG), we
evaluated all follow-up clinical data in 661 consecutive patients (775 SVG le-
sionsl from the JJIS multicenter registry (17 sites). Baseline demographics
were pertinent for a high incidence of unstable angina (72%), heart failure
(22%). and high surgical risk status (49%). The mean SVG age was 9 ± 4
years, and the mean ejection fraction was 49 ± 14%. Overall procedure suc-
cess «50% residual stenosis without in-hospital death. MI, or CABG) was
92%, and subacute thrombosis was documented in 9 patients (14%).
SVG Age >4 years
34±0.6[6 ± 101
2.3 ± 1.3133 ± 361
28.7
97.0
1.7/04/09
54/9.5
77.0
SVG Age <4 years
33±0.717 ±121
2.1 ± 1.3142 ± 361
35.6
971
14/0/14
57/143
730
Angiographic results PICA Stent Clinical Events 1%) PICA Stent
Vessel diameter (mm) 3.21 3.18 Death 3.3 59
Baseline mid (mm) 0.98 093 O-wave MI 1.7 1.5
Final mid (mm) 2.12 2.85' Bypass Surgery 67 0"
Final % diam stenosis 33 12' Closure: S24 hrs 33 2.9
Procedure success (%) 85 96*>1: >24 hrs 1.7 0
, p < 0.01," p < 0.05 vs PICA
One or more major clinical events occurred in 11.7% of PTCA patients
vs 5.9% of Stent patients (p = ns). Crossover from assigned to alternative
therapy (including bypass surgery) was 13.3% for the PTCA group vs 1.5%
for the Stent group (p < 0.01). In conclusion, the preliminary findings of this
prospective trial indicate: (1) Elective stent placement in de novo saphenous
vein bypass graft lesions achieves a superior initial angiographic result com-
pared to balloon angioplasty; (2) Stents confer a salutary effect on early clini-
cal events with less frequent need for alterna1e therapies including coronary
bypass surgery.
Michael Savage, John Douglas, David Fischman, Sarah Fenton, Spencer King,
Carl Pepine, Steven Bailey, Paul Overlie, Jeffrey Werner, Martin Leon,
Richard Heuser, Jeffrey Brinker, Maurice Buchbinder, Richard Smalling,
David Snead, Randal Rake, Sharon Gebhardt, Richard Kerensky,
Thomas Wargovich, Sheldon Goldberg, SAVED Trial Investigators. Jefferson
Medical College, Philadelphia, PA
The purpose of this interim analysis of the SAVED Restenosis Trial was to
assess the acute results of balloon angioplasty (PTCA) and elective Palmaz-
Schatz coronary stent placement in the treatment of de novo venous bypass
graft lesions. As of August I, 1994, 128 patients (60 PTCA, 68 Stent) have
been enrolled at 13 centers. Baseline demographics were similar in both
groups. Mean graft ages in the PTCA and Stent groups were 9.8 ± 4.2 vs 9.7
± 4.5 years (p = ns). Initial angiographic results by core laboratory analysis
and clinical events from 0 to 30 days were as follows:
Angiographic Findings:
Final MLD (mm) [% stenosisl
Follow-up MLD 1% stenosis]
Restenosis (>50% stenosis)
Clinical Results: 1%)
Procedural success
In hospital deathlO-wave MIICABG
Follow-up target lesion CABG/PICA
12·month event free survival
1710-31 Stent Placement is Safe and Effective in the
Treatment of Older (>4 Years) Saphenous Vein Graft
Lesions
S. Chiu Wong, Ya Chien Chuang, Mun K. Hong, Augusto D. Pichard, Lowell
F. Saller, Kenneth M. Kent, Kathi Donovan, Donald S. Baim, Richard A. Schatz,
Martin B. Leon. Washington Hospital Center. Washington, DC
Conventional balloon angioplasty (PTCA) in older (>4 years) saphenous vein
grafts (SVGs) is associated with reduced procedural success and less favor-
able late clinical outcomes. To determine if stent (S) implantation neutral-
izes the adverse effects of SVG age on clinical events, we analyzed the early
and late results of 617 consecutive pts from the Palmaz-Schatz SVG S reg-
istry. In 69 pts (13.3%), SVG age was ::;4 (mean 2.1 ± 1.3) years and in 448
pts (86.7%), SVG age was >4 (mean 9.9 ± 3.5) years. There were no sig-
nificant differences in pt demographics and lesion characteristics between
the 2 groups. Procedural success was defined as successful S deployment
with <50% residual stenosis without major complications (death/ a-wave
Mil CABG). Follow-up angiograms were obtained in 63% of pts with SVG
SO 4 years and in 60% of pts with SVG > 4 years. MLD = minimal lumen
diameter.
